Sean Felix

440 total citations
17 papers, 299 citations indexed

About

Sean Felix is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Sean Felix has authored 17 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 9 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Sean Felix's work include Liver Disease Diagnosis and Treatment (14 papers), Liver Diseases and Immunity (5 papers) and Liver Disease and Transplantation (4 papers). Sean Felix is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Liver Diseases and Immunity (5 papers) and Liver Disease and Transplantation (4 papers). Sean Felix collaborates with scholars based in United States, Malaysia and Egypt. Sean Felix's co-authors include Zobair M. Younossi, Pegah Golabi, Rebecca Cable, Mehmet Sayıner, Munkhzul Otgonsuren, Aaron B. Koenig, Maria Stepanova, Thomas L. Jeffers, Brian Lam and Linda Henry and has published in prestigious journals such as Gastroenterology, PLoS ONE and Diabetes.

In The Last Decade

Sean Felix

17 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sean Felix United States 7 231 141 73 42 41 17 299
Elena Younossi United States 6 365 1.6× 188 1.3× 141 1.9× 54 1.3× 44 1.1× 14 420
Carlos Fernández‐Carrillo Spain 11 213 0.9× 184 1.3× 21 0.3× 66 1.6× 52 1.3× 29 364
Kaushal Madan India 7 199 0.9× 103 0.7× 62 0.8× 87 2.1× 37 0.9× 18 294
Hannah I. Awai United States 5 407 1.8× 175 1.2× 221 3.0× 101 2.4× 20 0.5× 5 439
Kimberly Ramirez United States 4 566 2.5× 411 2.9× 119 1.6× 64 1.5× 27 0.7× 6 589
Miguel Malespin United States 11 183 0.8× 125 0.9× 51 0.7× 79 1.9× 14 0.3× 33 338
Achim Kautz Germany 9 436 1.9× 342 2.4× 91 1.2× 27 0.6× 61 1.5× 21 500
Yin Mei Lee Singapore 8 213 0.9× 188 1.3× 43 0.6× 54 1.3× 7 0.2× 14 260
Jinho Jung United States 12 458 2.0× 306 2.2× 128 1.8× 66 1.6× 8 0.2× 20 504
Prowpanga Udompap United States 9 276 1.2× 253 1.8× 22 0.3× 46 1.1× 13 0.3× 22 341

Countries citing papers authored by Sean Felix

Since Specialization
Citations

This map shows the geographic impact of Sean Felix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Felix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Felix more than expected).

Fields of papers citing papers by Sean Felix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Felix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Felix. The network helps show where Sean Felix may publish in the future.

Co-authorship network of co-authors of Sean Felix

This figure shows the co-authorship network connecting the top 25 collaborators of Sean Felix. A scholar is included among the top collaborators of Sean Felix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean Felix. Sean Felix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Younossi, Zobair M., Sean Felix, Brian Lam, et al.. (2025). Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver Disease. Journal of Clinical and Experimental Hepatology. 15(4). 102549–102549. 1 indexed citations
2.
Younossi, Zobair M., Michael Estep, Sean Felix, et al.. (2024). Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver disease. Diabetes Research and Clinical Practice. 219. 111960–111960. 2 indexed citations
3.
Younossi, Zobair M., Maria Stepanova, Sean Felix, et al.. (2023). The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 57(12). 1417–1422. 3 indexed citations
4.
Younossi, Zobair M., Yusuf Yılmaz, Mohamed El‐Kassas, et al.. (2022). The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry. Hepatology Communications. 6(10). 2860–2866. 3 indexed citations
5.
Stepanova, Maria, Brian Lam, Elena Younossi, et al.. (2022). The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19. BMC Infectious Diseases. 22(1). 702–702. 31 indexed citations
6.
Younossi, Zobair M., Maria Stepanova, Brian Lam, et al.. (2021). Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection. Hepatology Communications. 6(11). 3062–3072. 36 indexed citations
7.
Younossi, Zobair M., Sean Felix, Thomas L. Jeffers, et al.. (2021). Serum Biomarkers are Associated With Atherosclerotic Cardiovascular Disease Among Patients With Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography. Clinical Gastroenterology and Hepatology. 20(5). e1149–e1156. 3 indexed citations
8.
Younossi, Zobair M., Sean Felix, Thomas L. Jeffers, et al.. (2021). Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease. JAMA Network Open. 4(9). e2123923–e2123923. 42 indexed citations
9.
Karrar, Azza, Dinan Abdelatif, Ali Moosvi, et al.. (2020). Major Histocompatibility Complex Class I‐Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease. Hepatology Communications. 5(1). 63–73. 6 indexed citations
10.
Younossi, Zobair M., Sean Felix, Thomas L. Jeffers, et al.. (2020). 1448-P: Enhanced Liver Fibrosis (ELF) Test Can Accurately Predict Advanced Fibrosis in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease (NAFLD). Diabetes. 69(Supplement_1). 1 indexed citations
11.
Sayıner, Mehmet, et al.. (2019). Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States. Hepatology Communications. 3(3). 356–364. 13 indexed citations
12.
Mehta, Rohini, Peter M. Masschelin, Sean Felix, et al.. (2018). Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH). PLoS ONE. 13(6). e0199294–e0199294. 19 indexed citations
14.
Elsheikh, Elzafir, Sean Felix, Thomas L. Jeffers, et al.. (2017). Inducible Nitric Oxide Synthase is Independently Associated with the Increased Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease (NAFLD). Gastroenterology. 152(5). S684–S685. 3 indexed citations
16.
Golabi, Pegah, Munkhzul Otgonsuren, Rebecca Cable, et al.. (2016). Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL). Health and Quality of Life Outcomes. 14(1). 18–18. 115 indexed citations
17.
Koenig, Aaron B., et al.. (2016). Vaccination against hepatitis A and B in patients with chronic liver disease and type 2 diabetes: has anything changed?. Liver International. 36(8). 1096–1100. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026